|
000
| 01943nam 2200325za 4500 |
|---|
| 001 | 9.824615 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107144151 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 160922s2016 onc ob f000 0 eng d |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH113-27/2016-17E-PDF |
|---|
| 245 | 00|aCyfluthrin |h[electronic resource]. |
|---|
| 246 | 17|aProposed re-evaluation decision - PRVD2016-17 |
|---|
| 260 | |aOttawa : |bHealth Canada, |cc2016. |
|---|
| 300 | |a118 p. |
|---|
| 490 | 1 |aProposed re-evaluation decision, |x1925-0967 ; |vPRVD2016-17 |
|---|
| 500 | |aIssued also in French under title: Cyfluthrine. |
|---|
| 500 | |a“16 September 2016.” |
|---|
| 504 | |aIncludes references. |
|---|
| 520 | |a"An evaluation of available scientific information has determined that under the currently labelled conditions of use, the human health risks estimated for cyfluthrin meet current standards for most uses. As a requirement for the continued registration of cyfluthrin, new risk-reduction measures are proposed for the commercial-class end-use products registered in Canada. Based on potential risks of concern for residential exposure, all domestic-class products are proposed for cancellation and some residential uses are also proposed to be removed. Consideration of any additional data/information submitted during the consultation period to further refine the health risk assessment may or may not result in a change to this proposal"--Overview. |
|---|
| 530 | |aIssued also in print. |
|---|
| 692 | 07|2gccst|aInsecticides |
|---|
| 692 | 07|2gccst|aCertification |
|---|
| 692 | 07|2gccst|aToxicology |
|---|
| 710 | 1 |aCanada. |bPest Management Regulatory Agency. |
|---|
| 775 | 08|tCyfluthrine |w(CaOODSP)9.824617 |
|---|
| 830 | #0|aProposed re-evaluation decision (Canada. Pest Management Regulatory Agency)|x1925-0967 ; |vPRVD2016-17|w(CaOODSP)9.505201 |
|---|
| 856 | 40|qPDF|s946 KB|uhttps://publications.gc.ca/collections/collection_2016/sc-hc/H113-27-2016-17-eng.pdf |
|---|